Perianesthesia Implications and Considerations for Drug-Induced QT Interval Prolongation (1.25 CH - DC)

  • Registration Closed

Authors: Edwin N. Aroke, PhD, CRNA, Rolland Z. Nkemazeh, MD
Prolongation of the QT interval can predispose patients to fatal arrhythmias such as torsade de pointes. While arrhythmias can occur spontaneously in patients with a genetic predisposition, drugs such as ondansetron and droperidol, which are frequently used in the perioperative period, have been implicated in the prolongation of the QT interval. As the list of medications that cause QT prolongation grows, anesthesia providers and perioperative nurses must be informed regarding the importance of the QT interval. This article reviews the physiology and measurement of the QT interval, the risk factors of QT prolongation, the mechanism of drug-induced QT prolongation, and perioperative considerations for patient care.

Key:

Complete
Failed
Available
Locked
Demographic Survey
10 Questions
10 Questions Demographic Survey: Perianesthesia Implications and Considerations for Drug-Induced QT Interval Prolongation
Accreditation Information
Open to download resource.
Open to download resource. Accreditation Information: Perianesthesia Implications and Considerations for Drug-Induced QT Interval Prolongation
Article
Open to download resource.
Open to download resource. Article: Perianesthesia Implications and Considerations for Drug-Induced QT Interval Prolongation (1.25 CH - DC)
Post-test
10 Questions  |  Unlimited attempts  |  10/10 points to pass
10 Questions  |  Unlimited attempts  |  10/10 points to pass Post-test: Perianesthesia Implications and Considerations for Drug-Induced QT Interval Prolongation - 100% Required to Pass
Overall Evaluation
4 Questions
4 Questions Overall Evaluation: Perianesthesia Implications and Considerations for Drug-Induced QT Interval Prolongation
Certificate
1.25 Contact Hours available  |  Certificate available
1.25 Contact Hours available  |  Certificate available Certificate - Perianesthesia Implications and Considerations for Drug-Induced QT Interval Prolongation